Synopsys, Inc. vs Vanguard International High Dividend Yield ETF — how do they compare? Synopsys, Inc. trades at $509.99 (market cap $95.39B), while Vanguard International High Dividend Yield ETF trades at $100.66 (market cap $22.80B). The key difference: Synopsys, Inc. is far larger — about 4.2× Vanguard International High Dividend Yield ETF's market cap, and Synopsys, Inc. is trading nearer its 52-week high, Vanguard International High Dividend Yield ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Synopsys, Inc. for 71 Days and Vanguard International High Dividend Yield ETF for 50 Days on average.
| SNPS | VYMI | |
|---|---|---|
Market Cap | $95.39B | $22.80B |
Volume | 3,374,903 | 748,441 |
Sector | Technology | Broad Market / Factor |
52-Week High | $534.56 | $107.13 |
52-Week Low | $367.70 | $82.92 |
Typical Hold Time | 71 Days | 50 Days |
Enterprise Value | $102.62B | — |
Signals from Pluang's Aura AI — not financial advice
Synopsys (SNPS) trades at $497.75, down 0.98% on the day, but maintains strong momentum with three consecutive quarterly earnings beats. The stock shows bullish technical signals with moving averages supporting upward trends, though RSI levels suggest potential overbought conditions. Recent AI partnerships with OpenAI and Amazon, along with raised 2027 guidance, have driven significant investor optimism and a 13% surge in early October 2026.
The outlook remains positive with 93% analyst buy ratings and a $572.54 consensus price target representing 15% upside. Key risks include high valuation multiples (P/E 86.87) and integration challenges from the Ansys acquisition. Revenue growth acceleration to $9.4B projected for 2026 and expanding AI-driven chip design opportunities support the bullish case, though investors should monitor execution on ambitious growth targets.
VYMI trades at $100.66, up 0.43% on the day, with a bearish technical signal from moving averages but neutral oscillators. The ETF focuses on international high dividend yield stocks, with recent institutional buying activity from Envestnet and Corient Private Wealth. Recent news highlights strong performance with a 29% one-year return and 14.13% five-year average annual return, supported by financials, energy, and healthcare sector exposure.
The outlook remains positive given Vanguard's bullish stance on international developed markets and the ETF's attractive dividend yield. Key risks include global economic volatility and currency fluctuations, but institutional accumulation and sector alignment with rising rates support the investment thesis for income-focused investors seeking international diversification.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →